Impact China
Sort by
47 items
-
World - Financial Times
China’s WuXi explores sale of pharma units as US restrictions loom
Drugmakers have been targeted on national security grounds and could lose customers if Congress passes Biosecure ActYesterday - China -
World - Financial Times
Retail investors can sustain China’s market bounce
Beijing’s stimulus efforts may not be enough to win over battered foreign investorsYesterday - China -